EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells

Brittany P Rickard iD, Meghan M Dillon, Lauren A Sapienza-Lundie, Suzanne E Fenton, Imran Rizvi iD

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.70048 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2025. Written by Brittany P Rickard and 4 co-authors. Institution: Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA. Major MEDLINE topics: Ovarian Neoplasms, Fluorocarbons, Drug Resistance, Neoplasm, Photochemotherapy. 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIEHS NIH HHS, NC State Office of Research and Innovation, UNC-NC State Joint Department of Biomedical Engineering.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Photodynamic therapy (PDT) is a photochemistry‐based treatment modality that synergizes with traditional agents and can overcome chemoresistance. Eighty percent of ovarian cancer patients develop chemoresistant disease, highlighting the need to identify sources of treatment failure and develop rational combinations. Studies have shown that perfluoroalkyl substances (PFAS) induce chemoresistance in a duration‐dependent manner in OVCAR‐3 cells. PFAS are widespread drinking water contaminants present in the blood of nearly all Americans. The present study evaluated the ability of photodynamic priming (PDP), a sub‐cytotoxic variant of PDT, in combination with chemotherapy to overcome chemoresistance in two OVCAR‐3 cell cohorts: PFAS chronically‐exposed and outgrown (allowed to “recover” from chronic PFAS exposure). Effectiveness of benzoporphyrin derivative‐ (BPD‐) or aminolevulinic acid‐induced protoporphyrin IX‐PDP (ALA‐PpIX‐PDP) was assessed in combination with carboplatin and doxorubicin. In PFAS chronically‐exposed cells, BPD‐PDP + carboplatin reduced survival fraction compared to carboplatin alone. Mitochondrial membrane potential also decreased significantly in both cohorts following ALA‐PpIX‐PDP‐based combinations. PDP + doxorubicin also successfully overcame chemoresistance arising from chronic PFAS exposure but was less effective than PDP + carboplatin. Together, these findings demonstrate the efficacy of PDP‐based combinations in overcoming chronic PFAS exposure‐induced chemoresistance and should be explored in pre‐clinical models of ovarian cancer.

Subjects

MeSH terms (MEDLINE)

Ovarian NeoplasmsFluorocarbonsDrug Resistance, NeoplasmPhotochemotherapyPhotosensitizing AgentsFemaleHumansCell Line, Tumor

Author keywords

PFASmitochondriaovarian cancerphotodynamic therapyplatinumrecovery

Substances

FluorocarbonsPhotosensitizing Agents

Authors and institutions

  • Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
  • Curriculum in Toxicology & Environmental Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
  • Toxicology Program, Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
  • Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

ORCID profiles: Brittany P Rickard, Imran Rizvi

Funding

  • NIEHS NIH HHS
  • NC State Office of Research and Innovation
  • UNC-NC State Joint Department of Biomedical Engineering
  • NCI NIH HHS
  • National Institute of Environmental Health Sciences
  • National Cancer Institute

Cite

APA

Rickard, B. P., Dillon, M. M., Sapienza-Lundie, L. A., Fenton, S. E., & Rizvi, I. (2025). Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells. Photochemistry and Photobiology. https://doi.org/10.1111/php.70048

Vancouver

Rickard BP, Dillon MM, Sapienza-Lundie LA, Fenton SE, Rizvi I. Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells. Photochemistry and Photobiology. 2025. doi:10.1111/php.70048

BibTeX
@article{Rickard2025,
  author = {Rickard, Brittany P and Dillon, Meghan M and Sapienza-Lundie, Lauren A and Fenton, Suzanne E and Rizvi, Imran},
  title = {Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.70048}
}
Start for free →